Facetten
Zugriff
Einrichtung
Medientyp
- Text 13
Karte
Erscheinungsjahr
Autor/in
- Cortes, Jorge E
- Kantarjian, Hagop M 9
- Gambacorti-Passerini, Carlo 8
- Brümmendorf, Tim H 7
- Kim, Dong-Wook 7
- alle zeigen
Sprache
- Englisch 13
13 Einträge gefunden
-
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
- Cortes, Jorge E
- Heidel, Florian H
- Fiedler, Walter
- Smith, B Douglas
- Robak, Tadeusz
- Montesinos, Pau
- Candoni, Anna
-
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
- Cortes, Jorge E
- Heidel, Florian H
- Hellmann, Andrzej
- Fiedler, Walter
- Smith, B Douglas
- Robak, Tadeusz
- Montesinos, Pau
-
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
- Gambacorti-Passerini, Carlo
- Cortes, Jorge E
- Lipton, Jeff H
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Schafhausen, Philippe
- Crescenzo, Rocco
-
-
-
-
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
- Brümmendorf, Tim H
- Cortes, Jorge E
- Khoury, Hanna J
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Schafhausen, Philippe
- Conlan, Maureen G
-
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia:results from the 24-month follow-up of the BELA trial
- Brümmendorf, Tim H
- Cortes, Jorge E
- de Souza, Cármino Antonio
- Guilhot, Francois
- Duvillié, Ladan
- Pavlov, Dmitri
- Gogat, Karïn
-
-
-
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors
- Kantarjian, Hagop M
- Cortes, Jorge E
- Kim, Dong-Wook
- Khoury, H Jean
- Brümmendorf, Tim H
- Porkka, Kimmo
- Martinelli, Giovanni
-
-